Emmanuel Brouillet

14.1k total citations · 1 hit paper
156 papers, 10.5k citations indexed

About

Emmanuel Brouillet is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Emmanuel Brouillet has authored 156 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Cellular and Molecular Neuroscience, 87 papers in Molecular Biology and 52 papers in Neurology. Recurrent topics in Emmanuel Brouillet's work include Genetic Neurodegenerative Diseases (80 papers), Mitochondrial Function and Pathology (55 papers) and Neuroscience and Neuropharmacology Research (42 papers). Emmanuel Brouillet is often cited by papers focused on Genetic Neurodegenerative Diseases (80 papers), Mitochondrial Function and Pathology (55 papers) and Neuroscience and Neuropharmacology Research (42 papers). Emmanuel Brouillet collaborates with scholars based in France, United States and Switzerland. Emmanuel Brouillet's co-authors include Philippe Hantraye, M. Flint Beal, Nicole Déglon, M. F. Beal, Robert J. Ferrante, Nicolas Bizat, Stéphane Palfi, Rachana Srivastava, Elsdon Storey and Neil W. Kowall and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Emmanuel Brouillet

155 papers receiving 10.3k citations

Hit Papers

Neurochemical and histologic characterization of striatal... 1993 2026 2004 2015 1993 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuel Brouillet France 57 6.6k 6.0k 3.0k 1.5k 1.1k 156 10.5k
Jean Paul Vonsattel United States 47 4.3k 0.6× 5.0k 0.8× 4.3k 1.4× 3.9k 2.6× 1.3k 1.3× 108 11.3k
Kyuya Kogure Japan 62 5.0k 0.8× 5.4k 0.9× 1.8k 0.6× 2.5k 1.7× 3.6k 3.4× 319 13.4k
Nils Henrik Diemer Denmark 46 5.3k 0.8× 3.0k 0.5× 1.5k 0.5× 1.3k 0.9× 2.4k 2.3× 166 9.6k
Steven M. Rothman United States 40 5.9k 0.9× 4.3k 0.7× 966 0.3× 1.3k 0.9× 1.4k 1.4× 103 10.0k
F. Javoy‐Agid France 49 5.2k 0.8× 3.3k 0.6× 5.2k 1.7× 1.9k 1.3× 1.6k 1.5× 109 10.4k
Gerald A. Dienel United States 45 3.6k 0.6× 3.5k 0.6× 965 0.3× 1.9k 1.3× 1.5k 1.4× 120 8.0k
Péter Klivènyi Hungary 40 2.3k 0.3× 3.1k 0.5× 1.9k 0.6× 1.0k 0.7× 780 0.7× 214 7.2k
Olga Pletniková United States 49 2.2k 0.3× 4.2k 0.7× 3.5k 1.2× 2.8k 1.9× 1.3k 1.3× 84 8.9k
Lucio Annunziato Italy 58 3.5k 0.5× 5.0k 0.8× 818 0.3× 1.4k 0.9× 886 0.8× 285 10.2k
Bernd Hamprecht Germany 55 5.2k 0.8× 6.0k 1.0× 702 0.2× 2.3k 1.5× 1.6k 1.5× 206 12.2k

Countries citing papers authored by Emmanuel Brouillet

Since Specialization
Citations

This map shows the geographic impact of Emmanuel Brouillet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Brouillet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Brouillet more than expected).

Fields of papers citing papers by Emmanuel Brouillet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Brouillet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Brouillet. The network helps show where Emmanuel Brouillet may publish in the future.

Co-authorship network of co-authors of Emmanuel Brouillet

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Brouillet. A scholar is included among the top collaborators of Emmanuel Brouillet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Brouillet. Emmanuel Brouillet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brouillet, Emmanuel & Alfred Edwin Yawson. (2022). Menstrual Hygiene Management and Resources for Adolescent Girls in an Urban Setting in Accra, Ghana. 8(1). 17–22.
2.
Senova, Sühan, Cyril Poupon, Julien Dauguet, et al.. (2018). Optogenetic Tractography for anatomo-functional characterization of cortico-subcortical neural circuits in non-human primates. Scientific Reports. 8(1). 3362–3362. 14 indexed citations
3.
Francelle, Laetitia, et al.. (2017). Contribution of Neuroepigenetics to Huntington’s Disease. Frontiers in Human Neuroscience. 11. 17–17. 39 indexed citations
4.
Francelle, Laetitia, Laurie Galvan, Marie‐Claude Gaillard, et al.. (2014). Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease. Human Molecular Genetics. 24(6). 1563–1573. 22 indexed citations
5.
Damiano, Maria, Elsa Diguet, Carole Malgorn, et al.. (2013). A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin. Human Molecular Genetics. 22(19). 3869–3882. 89 indexed citations
6.
Badin, Romina Aron, B. Spinnewyn, Marie‐Claude Gaillard, et al.. (2013). Correction: IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates. PLoS ONE. 8(1). 1 indexed citations
7.
Faideau, Mathilde, Jae-Hwan Kim, Kerry Cormier, et al.. (2010). In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects. Human Molecular Genetics. 19(15). 3053–3067. 250 indexed citations
8.
Damiano, Maria, Laurie Galvan, Nicole Déglon, & Emmanuel Brouillet. (2009). Mitochondria in Huntington's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802(1). 52–61. 220 indexed citations
9.
Benchoua, Alexandra, Yaël Trioulier, Elsa Diguet, et al.. (2008). Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II. Human Molecular Genetics. 17(10). 1446–1456. 54 indexed citations
10.
Drouet, Valérie, Valérie Perrin, Raymonde Hässig, et al.. (2008). Effects of long-term and global huntingtin silencing. Human Gene Therapy. 19(10). 1125–1126. 1 indexed citations
11.
Escartin, Carole, Karin Pierre, Emmanuel Brouillet, et al.. (2007). Activation of Astrocytes by CNTF Induces Metabolic Plasticity and Increases Resistance to Metabolic Insults. Journal of Neuroscience. 27(27). 7094–7104. 104 indexed citations
12.
Bantubungi, Kadiombo, David Blum, Laëtitia Cuvelier, et al.. (2007). Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington's disease. Molecular and Cellular Neuroscience. 37(3). 454–470. 68 indexed citations
13.
Escartin, Carole, Emmanuel Brouillet, Paolo Gubellini, et al.. (2006). Ciliary Neurotrophic Factor Activates Astrocytes, Redistributes Their Glutamate Transporters GLAST and GLT-1 to Raft Microdomains, and Improves Glutamate HandlingIn Vivo. Journal of Neuroscience. 26(22). 5978–5989. 75 indexed citations
14.
Zala, Diana, Alexandra Benchoua, Emmanuel Brouillet, et al.. (2005). Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment. Neurobiology of Disease. 20(3). 785–798. 66 indexed citations
15.
Bizat, Nicolas, Jean‐Michel Hermel, Frédéric Boyer, et al.. (2003). Calpain Is a Major Cell Death Effector in Selective Striatal Degeneration InducedIn Vivoby 3-Nitropropionate: Implications for Huntington's Disease. Journal of Neuroscience. 23(12). 5020–5030. 145 indexed citations
16.
Chaldée, Michel de, Marie‐Claude Gaillard, Nicolas Bizat, et al.. (2003). Quantitative Assessment of Transcriptome Differences Between Brain Territories. Genome Research. 13(7). 1646–1653. 26 indexed citations
17.
Massioui, Nicole El, et al.. (2001). Perseverative Behavior Underlying Attentional Set-Shifting Deficits in Rats Chronically Treated with the Neurotoxin 3-Nitropropionic Acid. Experimental Neurology. 172(1). 172–181. 35 indexed citations
18.
Ouary, Stéphane, Nicolas Bizat, Vincent Mittoux, et al.. (2000). Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies. Neuroscience. 97(3). 521–530. 91 indexed citations
19.
Palfi, Stéphane, D. Riché, Emmanuel Brouillet, et al.. (1997). Riluzole Reduces Incidence of Abnormal Movements but Not Striatal Cell Death in a Primate Model of Progressive Striatal Degeneration. Experimental Neurology. 146(1). 135–141. 34 indexed citations
20.
Chavoix, Chantal, Emmanuel Brouillet, Vincent de La Sayette, et al.. (1992). In vivo interactions of pentylenetetrazole with benzodiazepine receptors: lack of direct correlation between benzodiazepine receptor occupancy and convulsant potency of this drug. Elsevier eBooks. 8. 351–359. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026